To find the right sedation technique for different types of treatment methods and the right amount of sedatives so the chances of side effects happening can be reduced.
| INTRODUCTION
Endoscopy, an essential diagnostic procedure for gastrointestinal disorder, needs to have a routine follow-up for cancer health screening. However, because endoscopy is associated with pain and unpleasant memory, many patients feel anxious about this procedure.
This problem needed to be solved in order to increase patient compliance and treatment accuracy. Due to these reasons, many countries in the western hemisphere and Republic of Korea have begun to routinely use conscious sedation endoscopy for patients. 1, 2 Conscious sedation refers to a treatment method of administering sedatives so that patients can withstand unpleasant procedures. The American Society of Anesthesiology (ASA) categorizes sedation into four levels. 3 Statistically, the level of sedation that is needed for endoscopy is conscious sedation or moderate sedation. During such sedation, respiratory and cardiovascular functions of patients are voluntarily stabilized with clear response to stimulation of hearing and touching. 4 Benzodiazepine and opioid are two drugs that are regularly used for conscious sedation during endoscopy. Midazolam, a drug belong to benzodiazepine group, has strong ataraxia, amnestic, and sedation effect. Furthermore, if opioid is added with midazolam, sedation effects such as amnestic and analgesic effects are improved, ultimately leading to higher patient satisfaction. 5 However, there are drawbacks of using midazolam. It induces respiratory depression. Its time of onset action is too long and patient recovery is too slow. Due to these reasons, the use of propofol, which has faster induction of sedation and recovery, has been steadily increasing. Unfortunately, side effects of propofol can include hypotension and apnea. 6 Recently, the effectiveness of lowdose propofol sedation for diagnostic esophagogastroduodenoscopy (EGD) has been reported. 7, 8 This method is becoming popular because low-dose propofol sedation is associated with low incidence of respiratory depression. This method is much better than benzodiazepines due to its rapidity for both sedation and recovery. 7, 8 Based on results of a driving simulator, it has been previously recorded that the driving ability following low-dose propofol sedation is normal within the 60-min period. 8 In Republic of Korea, some patients receive EGD or colonoscopy separately because of time constraint, while others receive both EGD and colonoscopy at the same time.
Because of this reality, it is critical to find different sedation techniques for different procedures.
The objective of this study was to determine the correct sedation technique for different procedures and the right amount of sedatives to reduce the chance of side effects. In this study, propofol was used for base sedation. Low-dose midazolam was added to increase patient satisfaction.
| METHODS

| Patients and study design
Between October 2017 and February 2018, 400 consecutive patients referred for diagnostic EGD and 600 consecutive patients referred for diagnostic EGD with colonoscopy were observed through a single tertiary medical center. This was a retrospective cohort analysis conducted on prospectively collected data.
All the endoscopists and nurses received propofol sedation education and advanced cardiac life-supporting certification. All the procedures were done by three, experienced endoscopists, who are also faculty members at the hospital. Nurses who were professionally trained as endoscopic assistants were present to assist. The sedation procedure was assessed by the three endoscopists and three nurses.
All the endoscopists received advanced cardiac life-supporting certification.
Underlying diseases of patients were evaluated using ASA physical status classification. 9 Patients under-age of 18 years, over 80 years, and those who had diseases falling under ASA class III-IV were excluded from this study. Patients who had chronic alcoholism or that had been using sedatives or drugs like benzodiazepine for long period were also excluded as well.
| Sedation protocols
Those who underwent EGD only were assigned into E group. They If the level of target was not reached or patients were under sedated, 10 mg of propofol was additionally injected.
Those who underwent EGD with colonoscopy were assigned into EC group. They were also sub-divided into three groups: (a) Patients However, the pain did get relieved in all patients within 30 min. As an anticholinergic agent, intravenous injection of cimetropium bromide 5 mg (Bropium) was given as premedication.
The target level of sedation was moderate sedation, on the basis of ASA criteria, in all groups. 11 To determine the level of sedation, a standardized procedure based on ASA criteria was used. 3 The level of 
| Monitoring protocols
Baseline vital signs were recorded right before the procedure. Prior to sedation, all patients received intravenous cannulation. All patients were continuously monitored for heart rate (by use of a three-lead electrocardiogram), blood pressure (by use of an automated blood pressure cuff and serial measurements every 5 min), and oxygen saturation (by pulse oximetry) until full recovery. Respiratory effort, respiratory rate, and chest wall excursion were monitored by visual inspection and palpation. All monitoring results were recorded by trained sedation nurses every 5 min. When oxygen desaturation (peripheral oxygen saturation < 90%) lasted for more than 20 s, supplemental oxygen was given. Resuscitation equipment was available at all times within the endoscopy and recovery unit. The level of sedation was assessed every 3-5 min throughout the procedure, or when patients felt pain during the procedure, to achieve a moderate level of sedation on the basis of ASA criteria. 3 After completion of the endoscopic procedure, patients were transferred to the recovery unit for continued hemodynamic monitoring. The recovery status of the patients was assessed by use of the modified Aldrete score. 12 The criterion for discharge from the recovery unit to home was a modified
Aldrete score of 10. For safety reasons, conscious sedation was only performed when either a guardian or one of the family members were present. Patients were also told not do drive within the 6-h period post-examination.
| Outcome measurements
The primary objective was to compare sedation efficacy, focusing on recovery time of E and EC group. Sedation efficacy results included recovery time (time from completion of EGD or EGD with colonoscopy to reaching an Aldrete score of 10), sedation induction (time from first injection to onset of effective sedation), and sedation quality (as assessed by endoscopists, sedation nurses, and patients, scored at the end of the procedure). Changes such as pulse frequency decrease of more than 20% and oxygen saturation lower than 90%
for more than 20 s were ruled as significant. Paradoxical reactions such as hyperactivity and aggressiveness after administering drugs were checked. Observations were made to determine whether there were differences between E and EC groups and within their subgroups.
Nurses and endoscopists were asked to complete a questionnaire after they finished the procedure. pain, symptoms, and memory during recovery. 11 The questionnaires were based on "the evaluation for quality improvement," which was conducted by Ajou University Hospital.
| Statistical analysis
All statistical analyses were performed using IBM Statistics SPSS for (EC group) were verified through one-way ANOVA. Categorical variables such as sex, oxygen saturation, pulse rate, and remembering endoscopic insertion and withdrawal were verified through χ 2 -test. Statistical significance was considered when P-value was less than 0.05. (Tables 1 and 2 ). In terms of procedure-related time, no significant difference was shown between E group and EC group.
| RESULTS
| Baseline characteristics
| Sedation efficacy
Mean total dose of sedatives and analgesics administered, induction time, recovery time, patient cooperation by endoscopists, and patient tolerance are presented in Table 3 and Table 4 .
E group, those in E-b used 37.05 ± 9.70 mg of total propofol in dosage, which was significantly less (P < 0.001) than that used by patients in E-a (47.60 ± 11.96 mg). In terms of the induction time,
recovery time, and patient cooperation by endoscopists, there were no significant differences between the two subgroups. No statistically significant differences were found in terms of whether the patient remembered endoscopic insertion and withdrawal or whether the patient felt pain during the procedure. However, E-b showed significantly higher patient satisfaction than E-a (7.47 ± 1.25 vs 8.30 ± 0.98, P < 0.001) ( Table 3 ).
The total dosage of propofol used for patients in EC-a group was (Table 4 ).
| Safety analysis
When different types of cardiopulmonary complications were compared within the E group, bradycardia did not appear in any of its two subgroups. However, hypoxemia, another type of cardiopulmonary complication, occurred 4 ± 2.0 times in E-b group and 15 ± 7.5 times in E-a group. Thus, patients in E-b group had statistically lowered chance of getting hypoxemia than E-a group (P = 0.010). Paradoxical reaction or permanent injury did not occur in any of the two subgroups (Table 5) .
T T A B L E 3 Sedation efficacy data during esophagogastroduodenoscopy only (Table 6 ). 
T A B L E 4 Sedation efficacy data during esophagogastroduodenoscopy with colonoscopy
EC-a EC-b EC-c P-value
| DISCUSSION
Sedation during endoscopy provides comfort to patients who might have anxiety, pain, and unpleasant experience and memory. As the introduction of sedative as a pretreatment for endoscopy, its usage has been steadily increasing. In America, 98% of endoscopists are using sedatives for both upper gastrointestinal tract endoscopy and colonoscopy. 2 Midazolam, a water-soluble benzodiazepine drug, is commonly used as a sedative for patients in conscious state. Compared to diazepam, midazolam is much more effective. It can reach the highest blood density within 15 min. It has a short half-life. It also shows an antianxiety effect. 13 The effectiveness of midazolam depends on various factors such as dosage, age of patient, cardio pulmonary function, the speed of drug insertion, and the type of drug that is being used along with midazolam. 14 The use of high dosage of midazolam has resulted in hypoxemia in 41% of patients. 15 Propofol, an intravenous anesthetic, 16 is advantageous for outpatients due to its rapid sedative effect via its redistribution mechanism.
In addition, it leads to quick recovery of the patients with decreased adverse effects due to its high clearance rate. 17 These properties are the reasons why propofol is being used in pretreatment for upper gastrointestinal tract endoscopy and colonoscopy. 18, 19 Propofol may be intravenously infused to a patient through continuous or bolus administration. For bolus administration, multiple injections are required. Its recommended dosage is 0.75-1.0 mg/kg.
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A study that compared midazolam and propofol showed that propofol had higher sedative effect and shorter recovery time than midazolam. 21 However, propofol severely suppressed cardiopulmonary function compared to midazolam. Additionally, compared to other sedatives, suppression of respiration, apnea, and decrease in blood pressure were more frequent in propofol. 22 Therefore, decreased dosage of propofol is necessary.
According to the ASA, the concomitant use of midazolam and propofol shows synergistic effect and the dosage of propofol can be reduced. 16 For the colonoscopy patients less than the age of 60, the concomitant use of low dose midazolam and propofol has brought synergistic sedative effect as well as more comfort and shorter recovery time compared to concomitant use of midazolam and opioids. 22 The other study, which included patients over the age of 65, also
showed that the concomitant use of low dose midazolam and propofol is safer. 23 It is a well-known fact that the most important point to remember about conscious sedation during diagnostic endoscopy is that patients need to go through the treatment safely and comfortably. Just like this, this specific study showed that concomitant use of low dose midazolam decreases the chance of hypoxemia, which can also have an effect of increasing the reliability of the treatment. In different studies on sedatives for endoscopy, propofol is more effective than midazolam. 23, 24 Others have shown that simultaneous use of both midazolam and propofol has synergistic effect for sedation. 7, 22, 23 Concomitant use of midazolam and propofol allows physicians to reduce the amount of propofol, while achieving increased patient satisfaction and reduced recovery time compared to the use of midazolam alone. 22, 23 Mechanism of action for midazolam is related to increase of chloride conduction through gamma-aminobutyric acid receptor activation. 25 On the other hand, propofol changes neural transmission of gamma-aminobutyric acid, an inhibitory neurotransmitter. 26 This is the reason why it is believed that simultaneous injection of both sedatives has an interactive effect at cellular level. 27 Even subhypnotic dosage of propofol can bring out a strengthened sedative effect as long as midazolam is injected along with propofol.
Considering the fact that midazolam strengthens the calming effect of propofol, this study was conducted by concomitant use of low doses of midazolam and propofol. The dosage of propofol injected in concomitant usage of both propofol and midazolam was lower than the dosage of propofol injected in propofol-only treatment. 19, 24, 28 There was a significant difference in the amount of time for sedative to have its effect between the group of patients that underwent both EGD and colonoscopy by using the concomitant treatment and the group of patients that underwent both procedures through propofol-only treatment. When midazolam was used in high dosage, the effect lasted about 60 to 120 min. However, when it was used in low dosage, the recovery time was shortened to 20 min and the effect of midazolam wore off after 15 to 20 min of either gastroscopy or colonoscopy, which was the average time that it took for both procedures to get finished. This is the reason why it is hypothesized that majority of 0.025 mg/kg of low dose midazolam is metabolized during procedures. As time passes by, there will be difference between the two groups, because propofol is going to be the only sedative existing in the system. Like the study suggested, the group that concomitantly used low dose midazolam with propofol (E-b, ECb) both significantly and statistically decreased the amount of propofol being used compared to groups that only used propofol (E-a, EC-a).
This had the effect of decreasing the chance of hypoxemia happening, which naturally resulted in increase in both safety and patient satisfaction with sedation.
In a study where midazolam's and propofol's possible side effects and patients' or investigators' acceptance of the procedure have been looked at, the research has shown that when the most common regimens have been applied to these two drugs, both the patient acceptance and endoscopic diagnostic accuracy have come out to be satisfactory. [29] [30] [31] When midazolam is used in combination with an opioid analgesic, the dosage of midazolam/opioids may be decreased due to synergistic interaction. 32 According to Tsai et al., 33 meperidine cannot decrease the level of pain during colonoscopy. In our study, for those, who underwent both EGD and colonoscopy, there was no significant difference in pain level between patients who received meperidine and those who did not receive meperidine. It is believed that using low dose of both midazolam and propofol is enough to lower the pain level and show calming effect for patients. Paradoxical reaction is one of the side effects of using midazolam and it appears more frequently as the amount of midazolam being used increases. It is believed that paradoxical reaction did not occur in patients within the EC-a group because these patients were only administered with propofol while the patients within the EC-b and EC-c groups did show signs of paradoxical reaction because they were administered with midazolam for their treatments. However, because patients in EC-c, compared to patients in EC-a or EC-b, showed more signs of paradoxical movement, led the researchers to believe that meperidine causes paradoxical movement to occur more frequently. Additionally, because meperidine does not lead to any significant change in terms of decrease in pain level or patient satisfaction, it is believed that the usage of meperidine does not necessarily bring positive changes to the treatments.
There are certain groups of people who are difficult to be consciously sedated and often need more sedative medications during clinical anesthesia endoscopy practice. Chronic alcoholism and chronic benzodiazepine users are the examples. 34 This research did not include such groups of people and believe such addition can be looked at in the next study.
In EGD, a procedure that takes a short period, concomitant use of low dosages of both propofol and midazolam can decrease the overall amount of propofol being used, showing no difference in sedatives going in to the system. It can reduce the side effect of temporary hypoxemia compared to sole injection of propofol. For combined procedures of EGD and colonoscopy that take longer than 15 min, the following sedatives are usually used: 50 mg of meperidine, low dosage of propofol, and midazolam. However, this study showed that concomitant use of low dosages of both propofol and midazolam can allow physicians to completely avoid using opioid, thus decreasing the dosage of propofol. This ultimately resulted in reducing the side effect of temporary hypoxemia, increased patient satisfaction, faster recovery time, and lowered chance of paradoxical reaction occurring. These results demonstrate that concomitant use of low dosages of both propofol and midazolam is very useful and safe when endoscopy needs to be performed.
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